Biologics product developer Bacterin International Holdings (NYSEAMEX:BONE) announced late Wednesday it will be presenting at the Jefferies 2012 Global Healthcare Conference.
The maker of bone graft material and antimicrobial coatings for
medical applications will present on June 7th at 11:00AM (ET), at the
Jefferies 2012 Global Healthcare Conference, in New York, New York.
Bacterin's presentation will be webcast and available online at www.investor.bacterin.com.
The company recently unveiled, at the beginning of May, its third
national group purchasing organization (GPO) contract, announcing a
three-year agreement with health care supply chain company Novation.
The agreement provides Bacterin's full biologic portfolio to the
nationwide network of hospitals and medical practices served by
Novation.
The portfolio includes Bacterin's OsteoSponge, OsteoSelect DBM Putty,
OsteoWrap, OsteoLock, BacFast, hMatrix, Sports Medicine Allografts, and
traditional allografts.
Bacterin's technology optimizes the growth factors in human allografts to promote bone, subchondral repair and dermal growth.
The company's products are used in a variety of applications
including enhancing fusion in spine surgery, relief of back pain, bone
growth in foot and ankle surgery, cranial healing following neurosurgery
and subchondral repair in knee and other joint surgeries.
Proactiveinvestors is a leading multi-media news organisation, investor portal and events management business with offices in New York, Sydney, Toronto, Frankfurt and London.
No comments:
Post a Comment